Atlas Trials

Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix

Clinical trial NCT00518193 · TERMINATED

Trial details

NCT number
NCT00518193
Sponsor
ARCAGY/ GINECO GROUP
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cervix Cancer
Start date
2007-04-01
Primary completion
2007-07-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.